cetirizine has been researched along with Benign Neonatal Sleep Myoclonus in 1 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cetirizine is a histamine H1 antagonist that is US Food and Drug Administration approved for the treatment of allergic rhinitis and urticaria and has common adverse effects of drowsiness and headaches." | 4.02 | A case report of sleep terrors exacerbated by cetirizine. ( Aziz, SG; Hussain, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, S | 1 |
| Aziz, SG | 1 |
1 other study available for cetirizine and Benign Neonatal Sleep Myoclonus
| Article | Year |
|---|---|
A case report of sleep terrors exacerbated by cetirizine.
Topics: Adult; Cetirizine; Humans; Male; Night Terrors; Parasomnias; Rhinitis, Allergic; United States; Urti | 2021 |